C4b-binding protein, a regulatory component of the classical pathway of complement, is an acute-phase protein and is elevated in systemic lupus erythematosus.
A radioimmunoassay using monoclonal and polyclonal antihuman C4b-binding protein (C4BP) antibody was developed to quantitate C4BP in serum. Using the assay, the levels of C4BP in healthy individuals, in patients with systemic lupus erythematosus (SLE), and in acute-phase individuals were determined. The levels of C4BP are significantly elevated in individuals with SLE (186%; p = 0.0001) and are even higher in individuals during the acute phase (286%; p = 0.0001). To confirm whether or not individuals were in the acute-phase response, serum C-reactive protein (CRP) levels were assessed. In the acute-phase response, CRP levels were 100-fold elevated over normals, but did not correlate with increases in C4BP (r = -0.031; p = 0.899). In SLE patients, the CRP levels were significantly, but moderately, elevated (5-fold; p = 0.028). The data indicate that C4BP is an acute-phase reactant and is differentially regulated from CRP during the acute-phase response.
Department of Microbiology, University of Alabama, Birmingham.
S R
SR
Barnum
B
B
Dahlbäck
D000209:Acute-Phase Proteins; D000328:Adult; D002097:C-Reactive Protein / Q000032:analysis; D002352:Carrier Proteins / Q000097:blood*; D003169:Complement Inactivator Proteins; D003171:Complement Pathway, Classical; D006023:Glycoproteins; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood*; D011863:Radioimmunoassay; D011951:Receptors, Complement / Q000097:blood*
D000209:Acute-Phase Proteins; D002352:Carrier Proteins; D003169:Complement Inactivator Proteins; D006023:Glycoproteins; D011951:Receptors, Complement; D002097:C-Reactive Protein